UB Paderborn / Katalog / Suche / in CDI

Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor

Journal of medicinal chemistry, 1999-05, Vol.42 (10), p.1803-1815

1999

Volltextzugriff (PDF)

Substrate Specificity of the Protein Tyrosine Phosphatases

Proceedings of the National Academy of Sciences - PNAS, 1993-05, Vol.90 (10), p.4446-4450

1993

Volltextzugriff (PDF)

Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B

The Journal of biological chemistry, 1993-11, Vol.268 (31), p.23634-23639

1993

Volltextzugriff (PDF)

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (20), p.12022-12027

1998

Volltextzugriff (PDF)

Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4

Journal of medicinal chemistry, 2005-04, Vol.48 (7), p.2371-2387

2005

Volltextzugriff (PDF)

Determinants of Substrate Recognition in the Protein-tyrosine Phosphatase, PTP1 (∗)

The Journal of biological chemistry, 1996-03, Vol.271 (10), p.5386-5392

1996

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors. 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2'-Dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)

Journal of medicinal chemistry, 1994-06, Vol.37 (13), p.2033-2042

1994

Volltextzugriff (PDF)

Tyrosine kinase inhibitors. 1. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)

Journal of medicinal chemistry, 1993-08, Vol.36 (17), p.2459-2469

1993

Volltextzugriff (PDF)

Structure–activity relationships for 2-anilino-6-phenylpyrido[2,3- d]pyrimidin-7(8 H)-ones as inhibitors of the cellular checkpoint kinase Wee1

Bioorganic & medicinal chemistry letters, 2005-04, Vol.15 (7), p.1931-1935

2005

Volltextzugriff (PDF)

Identification of amino acids in the N-terminal SH2 domain of phospholipase C gamma 1 important in the interaction with epidermal growth factor receptor

Biochemistry (Easton), 1994-12, Vol.33 (49), p.14671

1994

Volltextzugriff (PDF)

2-Aminoquinazoline inhibitors of cyclin-dependent kinases

Bioorganic & medicinal chemistry letters, 2005-09, Vol.15 (17), p.3881-3885

2005

Volltextzugriff (PDF)

Differentiation of peptide molecular recognition by phospholipase Cγ‐1 Src homology‐2 domain and a mutant Tyr phosphatase PTP1bC215S

Protein science, 1995-01, Vol.4 (1), p.13-20

1995

Volltextzugriff (PDF)

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phosphorylation sites of phospholipase C-gamma 1

Peptides (New York, N.Y. : 1980), 1994, Vol.15 (6), p.951-957

1994

Volltextzugriff (PDF)

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phosphorylation sites of phospholipase C-γ1

Peptides (New York, N.Y. : 1980), 1994, Vol.15 (6), p.951-957

1994

Volltextzugriff (PDF)

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phsphorylation sites of phospholipase C-γ1

Peptides (New York, N.Y. : 1980), 1994, Vol.15 (6), p.951-957

1994

Volltextzugriff (PDF)

Tyrosine kinase inhibitors. III: Structure-activity relationships for inhibition of protein tyrosine kinase by nuclear-substituted derivatives of 2,2'-dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)

Journal of medicinal chemistry, 1994, Vol.37 (13), p.2033-2042

1994

Volltextzugriff (PDF)

Inhibition of binding of phospholipase C gamma 1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides

International journal of peptide and protein research, 1993-09, Vol.42 (3), p.240-248

1993

Volltextzugriff (PDF)

Tyrosine kinase inhibitors. I: Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)

Journal of medicinal chemistry, 1993, Vol.36 (17), p.2459-2469

1993

Volltextzugriff (PDF)

Inhibition of binding of phospholipase Cγ1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides

International Journal of Peptide and Protein Research, 1993-09, Vol.42 (3), p.240-248

1993

Volltextzugriff (PDF)

Substrates specificity of the protein tyrosine phosphatases

Proceedings of the National Academy of Sciences - PNAS, 1993, Vol.90 (10), p.4446-4450

1993

Volltextzugriff (PDF)

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2′-Dithiobis(1-methyl-N-phenyl-1H-indole-3- carboxamide)

ChemInform, 1994-12, Vol.25 (50), p.no-no

1994

Volltextzugriff (PDF)

Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases

Journal of medicinal chemistry, 2000-11, Vol.43 (24), p.4606-4616

2000

Volltextzugriff (PDF)

Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6

The Journal of biological chemistry, 2001-05, Vol.276 (20), p.16617-16623

2001

Volltextzugriff (PDF)

Attentional Asymmetry in Schizophrenia: Disengagement and Inhibition of Return Deficits

Neuropsychology, 2001-07, Vol.15 (3), p.361-370

2001

Volltextzugriff (PDF)

C-Terminal Modifications of Histidyl-N-benzylglycinamides To Give Improved Inhibition of Ras Farnesyltransferase, Cellular Activity, and Anticancer Activity in Mice

Journal of medicinal chemistry, 1997-10, Vol.40 (21), p.3319-3322

1997

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor

Substrate Specificity of the Protein Tyrosine Phosphatases

Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4

Determinants of Substrate Recognition in the Protein-tyrosine Phosphatase, PTP1 (∗)

Tyrosine Kinase Inhibitors. 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2'-Dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)

Tyrosine kinase inhibitors. 1. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)

Structure–activity relationships for 2-anilino-6-phenylpyrido[2,3- d]pyrimidin-7(8 H)-ones as inhibitors of the cellular checkpoint kinase Wee1

Identification of amino acids in the N-terminal SH2 domain of phospholipase C gamma 1 important in the interaction with epidermal growth factor receptor

2-Aminoquinazoline inhibitors of cyclin-dependent kinases

Differentiation of peptide molecular recognition by phospholipase Cγ‐1 Src homology‐2 domain and a mutant Tyr phosphatase PTP1bC215S

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phosphorylation sites of phospholipase C-gamma 1

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phosphorylation sites of phospholipase C-γ1

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phsphorylation sites of phospholipase C-γ1

Tyrosine kinase inhibitors. III: Structure-activity relationships for inhibition of protein tyrosine kinase by nuclear-substituted derivatives of 2,2'-dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)

Inhibition of binding of phospholipase C gamma 1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides

Tyrosine kinase inhibitors. I: Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)

Inhibition of binding of phospholipase Cγ1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides

Substrates specificity of the protein tyrosine phosphatases

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2′-Dithiobis(1-methyl-N-phenyl-1H-indole-3- carboxamide)

Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases

Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6

Attentional Asymmetry in Schizophrenia: Disengagement and Inhibition of Return Deficits

C-Terminal Modifications of Histidyl-N-benzylglycinamides To Give Improved Inhibition of Ras Farnesyltransferase, Cellular Activity, and Anticancer Activity in Mice

Suchergebnisse filtern